Avantor (NYSE:AVTR) PT Lowered to $28.00

Avantor (NYSE:AVTR - Free Report) had its price target cut by Wells Fargo & Company from $30.00 to $28.00 in a research note published on Monday, Benzinga reports. They currently have an overweight rating on the stock.

Other equities analysts also recently issued reports about the stock. Barclays reduced their target price on shares of Avantor from $28.00 to $25.00 and set an "overweight" rating for the company in a report on Friday. Royal Bank of Canada reiterated an "outperform" rating and set a $34.00 price objective on shares of Avantor in a report on Thursday, September 26th. Morgan Stanley boosted their target price on Avantor from $28.00 to $29.00 and gave the stock an "overweight" rating in a research note on Monday, July 29th. Evercore ISI lowered their price target on Avantor from $28.00 to $27.00 and set an "outperform" rating for the company in a report on Tuesday, July 2nd. Finally, TD Cowen upped their price objective on shares of Avantor from $28.00 to $31.00 and gave the company a "buy" rating in a report on Monday, July 29th. Three investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, Avantor presently has a consensus rating of "Moderate Buy" and an average price target of $27.57.

Avantor Trading Up 0.9 %

AVTR traded up $0.20 during trading on Monday, hitting $22.63. 4,587,843 shares of the stock were exchanged, compared to its average volume of 6,440,935. Avantor has a 1 year low of $16.63 and a 1 year high of $28.00. The firm has a market cap of $15.37 billion, a price-to-earnings ratio of 58.00, a P/E/G ratio of 2.93 and a beta of 1.33. The firm has a 50 day simple moving average of $25.49 and a 200 day simple moving average of $24.26. The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.05 and a current ratio of 1.59.

Avantor (NYSE:AVTR - Get Free Report) last released its quarterly earnings data on Friday, July 26th. The company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.02. Avantor had a return on equity of 12.40% and a net margin of 5.28%. The firm had revenue of $1.70 billion during the quarter, compared to the consensus estimate of $1.70 billion. As a group, equities analysts expect that Avantor will post 1.01 EPS for the current year.

Insider Activity

In other news, CAO Steven W. Eck sold 3,525 shares of the stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $25.06, for a total transaction of $88,336.50. Following the sale, the chief accounting officer now directly owns 29,544 shares of the company's stock, valued at $740,372.64. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 1.50% of the company's stock.

Hedge Funds Weigh In On Avantor

Several hedge funds and other institutional investors have recently made changes to their positions in AVTR. Versant Capital Management Inc lifted its stake in Avantor by 2,003.6% in the 2nd quarter. Versant Capital Management Inc now owns 1,157 shares of the company's stock worth $25,000 after purchasing an additional 1,102 shares in the last quarter. Blue Trust Inc. grew its holdings in shares of Avantor by 1,830.3% in the second quarter. Blue Trust Inc. now owns 1,467 shares of the company's stock valued at $31,000 after purchasing an additional 1,391 shares during the period. UMB Bank n.a. acquired a new position in Avantor in the 3rd quarter valued at about $49,000. Nisa Investment Advisors LLC grew its position in Avantor by 69.6% in the third quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company's stock worth $53,000 after acquiring an additional 835 shares during the period. Finally, GAMMA Investing LLC increased its position in shares of Avantor by 89.9% during the 3rd quarter. GAMMA Investing LLC now owns 2,715 shares of the company's stock worth $70,000 after purchasing an additional 1,285 shares during the last quarter. Hedge funds and other institutional investors own 95.08% of the company's stock.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.